Skip to content
Bomb Report – Lifestyle
Author:
RxBenefits
RxBenefits Releases Pharmacy Benefits Market Report to Help Benefits Advisors Evaluate Transparent PBMs
August 10, 2026
RxBenefits Names Tim Kessler President to Advance Client Advocacy, Technology, and AI Innovation
May 18, 2026
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
May 16, 2026
RxBenefits Releases Q1 2026 Pharmacy Benefits Market Report
May 14, 2026